Qingyi Yang

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.9K citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Molecular Transformer unifies reaction prediction and retrosynthesis across pharma chemical space

Alpha A. Lee, Qingyi Yang, Vishnu Sresht et al. · Chemical Communications · 2019 · 143 citations

Natural Sciences, Chemistry, Computational Chemistry +10

Genetic Surveillance of SARS-CoV-2 M ^pro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid

Jonathan T. Lee, Qingyi Yang, Alexey V. Gribenko et al. · mBio · 2022 · 91 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase

Yuan Xu, Qingyi Yang, Tongyan Liu et al. · European Journal of Medicinal Chemistry · 2019 · 77 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB

Michael F. Mesleh, Jason B. Cross, Jing Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 73 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12